Technology

Fennec Pharmaceuticals

$8.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.35 (+4.48%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FENC and other stocks, options, and ETFs commission-free!

About FENC

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC. The listed name for FENC is Fennec Pharmaceuticals Inc. Common Stock.

CEO
Rostislav C. Raykov
Employees
4
Headquarters
Durham, North Carolina
Founded
1996
Market Cap
206.05M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
93.83K
High Today
$8.19
Low Today
$7.71
Open Price
$7.71
Volume
91.07K
52 Week High
$10.67
52 Week Low
$4.65

Collections

FENC Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, Pre-Market

You May Also Like

WRLD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure